Dr. David Petros is a rheumatologist in Corpus Christi,Texas. He graduated from University of Pittsburgh School of Medicine in 1982 and has been in practice for 40 years.
Male
1154306603
| Description | # of Times Performed | # of Patients | Average Charge ($) |
|---|---|---|---|
| Injections of tendon sheath, ligament, or muscle membrane | 24.0 | 17.0 | 113.23 |
| Aspiration and/or injection of small joint or joint capsule | 64.0 | 17.0 | 105.87875 |
| Aspiration and/or injection of large joint or joint capsule | 62.0 | 33.0 | 127.42967742 |
| Bone density measurement using dedicated X-ray machine | 38.0 | 38.0 | 77.08 |
| Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | 18.0 | 15.0 | 32.44 |
| Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | 52.0 | 13.0 | 32.12 |
| Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle | 105.0 | 25.0 | 151.88 |
| Infusion of chemotherapy into a vein up to 1 hour | 508.0 | 74.0 | 268.84 |
| Infusion of chemotherapy into a vein | 227.0 | 37.0 | 58.78 |
| New patient office or other outpatient visit, typically 45 minutes | 47.0 | 47.0 | 321.74 |
| Established patient office or other outpatient visit, typically 15 minutes | 975.0 | 347.0 | 144.92 |
| Established patient office or other outpatient, visit typically 25 minutes | 65.0 | 56.0 | 212.56 |
| Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 16425.0 | 25.0 | 103.23 |
| Injection, denosumab, 1 mg | 2220.0 | 22.0 | 37.22 |
| Injection, methylprednisolone acetate, 20 mg | 14.0 | 12.0 | 8.02 |
| Injection, methylprednisolone acetate, 40 mg | 41.0 | 30.0 | 13.2 |
| Injection, infliximab, excludes biosimilar, 10 mg | 8710.0 | 27.0 | 153.3 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 411.0 | 42.0 | 3.4 |
Cookies on this website are used to improve your experience and display advertising. You agree to the use of cookies by continuing to use this website. Our Privacy Policy contains more information about how we use cookies.